Profile
The RespirAct™ is a computer-controlled gas blender used to control arterial CO2 and O2 in spontaneously breathing participants. Changing the partial pressure of CO2 and O2 in the blood is done to stimulate blood flow responses in organs which can then be monitored using imaging technology (i.e. TCD or MRI). Monitoring blood flow response to blood gas changes in these organs reveals aspects related to their vascular beds. This technology has many potential applications, including understanding the mechanisms of injury in stroke patients. In the U.S., RespirAct™ is available for investigational purposes only and is distributed by Thornhill Medical for use in IRB-approved basic physiological research studies.
Website
Contact
-
Vepeson Wijeyakulasingam, Clinical Market Development ManagerEmail: vwijeya@thornhillmedical.com
-
-
-
-
-
Event details
Name: Ontario at RSNA 2022
Date: November 27 - December 1, 2022
Event contact
Patricia Cosgrove
Area Director
USA: Life Sciences
Tel: +1 647-293-6306
Email: patricia.cosgrove@ontario.ca
Participants
6 in total
-
The ALTA platform™ is an intelligent robotic system that automates transfers of supine individuals who need to be… -
Altis is a clinical information company advancing medical research and knowledge. Their team is on a mission to guide… -
DQE Instruments manufactures the industry-standard instrument (DQEPro) for DQE (… -
Leafsprout offers secure cloud-based solutions for the management of imaging exams and reports—within and across… -
RamSoft is the SaaS imaging IT vendor that helps healthcare providers deliver faster, empowered care. We… -
The RespirAct™ is a computer-controlled gas blender used to control arterial CO2…